Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates ᅢᄁ¬ツᆲ¬タン including cancer, neurodegeneration, and metabolic disease. Dewpoint scientists are working in Boston, MA, and Dresden, Germany, to translate condensate biology into treatments for the toughest diseases.
Dewpoint Therapeutics Address
451 D Street Boston, MA United States
Dewpoint Therapeutics Email
Past Companies
Dewpoint TherapeuticsVice President, Head of Neurological & Rare Diseases